Lonza Group Valuation
Is LONNz undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of LONNz when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: LONNz (CHF532) is trading below our estimate of fair value (CHF1016.55)
Significantly Below Fair Value: LONNz is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for LONNz?
Key metric: As LONNz is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
What is LONNz's PE Ratio? | |
---|---|
PE Ratio | 67.1x |
Earnings | CHF 573.00m |
Market Cap | CHF 38.45b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 6x |
Enterprise Value/EBITDA | 21.9x |
PEG Ratio | 2.9x |
Price to Earnings Ratio vs Peers
How does LONNz's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 26.8x | ||
ERGO Ergomed | 46.7x | 14.2% | UK£701.1m |
GSK GSK | 21.8x | 23.2% | UK£54.7b |
HVO hVIVO | 7.6x | -29.6% | UK£132.7m |
AZN AstraZeneca | 31.2x | 18.2% | UK£161.8b |
LONNz Lonza Group | 67.1x | 23.4% | CHF 38.5b |
Price-To-Earnings vs Peers: LONNz is expensive based on its Price-To-Earnings Ratio (67.1x) compared to the peer average (20.2x).
Price to Earnings Ratio vs Industry
How does LONNz's PE Ratio compare vs other companies in the European Life Sciences Industry?
1 Company | Price / Earnings | Estimated Growth | Market Cap |
---|---|---|---|
1 Company | Estimated Growth | Market Cap | |
---|---|---|---|
Price-To-Earnings vs Industry: LONNz is expensive based on its Price-To-Earnings Ratio (67.1x) compared to the European Life Sciences industry average (37.5x).
Price to Earnings Ratio vs Fair Ratio
What is LONNz's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 67.1x |
Fair PE Ratio | 36.9x |
Price-To-Earnings vs Fair Ratio: LONNz is expensive based on its Price-To-Earnings Ratio (67.1x) compared to the estimated Fair Price-To-Earnings Ratio (36.9x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CHF 532.00 | CHF 636.90 +19.7% | 6.8% | CHF 723.00 | CHF 530.00 | n/a | 20 |
Dec ’25 | CHF 525.80 | CHF 632.71 +20.3% | 7.7% | CHF 760.00 | CHF 530.00 | n/a | 21 |
Nov ’25 | CHF 549.60 | CHF 631.85 +15.0% | 7.9% | CHF 760.00 | CHF 530.00 | n/a | 20 |
Oct ’25 | CHF 534.60 | CHF 624.14 +16.7% | 6.4% | CHF 700.00 | CHF 530.00 | n/a | 21 |
Sep ’25 | CHF 553.60 | CHF 619.41 +11.9% | 7.0% | CHF 700.00 | CHF 530.00 | n/a | 22 |
Aug ’25 | CHF 588.80 | CHF 613.55 +4.2% | 8.0% | CHF 700.00 | CHF 495.00 | n/a | 22 |
Jul ’25 | CHF 488.40 | CHF 586.00 +20.0% | 9.4% | CHF 666.00 | CHF 450.00 | n/a | 22 |
Jun ’25 | CHF 487.10 | CHF 576.86 +18.4% | 12.1% | CHF 655.00 | CHF 375.00 | n/a | 22 |
May ’25 | CHF 512.60 | CHF 566.00 +10.4% | 12.1% | CHF 650.00 | CHF 375.00 | n/a | 22 |
Apr ’25 | CHF 540.40 | CHF 556.00 +2.9% | 12.8% | CHF 650.00 | CHF 375.00 | n/a | 22 |
Mar ’25 | CHF 467.20 | CHF 508.25 +8.8% | 13.3% | CHF 635.00 | CHF 365.00 | n/a | 20 |
Feb ’25 | CHF 427.30 | CHF 495.20 +15.9% | 14.0% | CHF 600.00 | CHF 365.00 | n/a | 20 |
Jan ’25 | CHF 353.90 | CHF 465.16 +31.4% | 18.5% | CHF 600.00 | CHF 270.00 | n/a | 19 |
Dec ’24 | CHF 335.90 | CHF 513.11 +52.8% | 21.9% | CHF 705.00 | CHF 365.00 | CHF 525.80 | 19 |
Nov ’24 | CHF 319.80 | CHF 531.26 +66.1% | 20.8% | CHF 705.00 | CHF 365.00 | CHF 549.60 | 19 |
Oct ’24 | CHF 426.40 | CHF 627.41 +47.1% | 8.5% | CHF 705.00 | CHF 514.00 | CHF 534.60 | 17 |
Sep ’24 | CHF 493.20 | CHF 629.83 +27.7% | 7.3% | CHF 705.00 | CHF 530.00 | CHF 553.60 | 18 |
Aug ’24 | CHF 505.20 | CHF 647.06 +28.1% | 6.9% | CHF 705.00 | CHF 570.00 | CHF 588.80 | 18 |
Jul ’24 | CHF 533.40 | CHF 679.24 +27.3% | 11.1% | CHF 900.00 | CHF 580.00 | CHF 488.40 | 17 |
Jun ’24 | CHF 575.40 | CHF 659.84 +14.7% | 16.9% | CHF 900.00 | CHF 315.05 | CHF 487.10 | 18 |
May ’24 | CHF 554.40 | CHF 663.36 +19.7% | 17.1% | CHF 900.00 | CHF 315.05 | CHF 512.60 | 17 |
Apr ’24 | CHF 547.80 | CHF 662.77 +21.0% | 17.1% | CHF 900.00 | CHF 315.05 | CHF 540.40 | 17 |
Mar ’24 | CHF 560.20 | CHF 662.89 +18.3% | 16.6% | CHF 900.00 | CHF 315.05 | CHF 467.20 | 18 |
Feb ’24 | CHF 520.20 | CHF 659.65 +26.8% | 18.0% | CHF 935.00 | CHF 315.05 | CHF 427.30 | 17 |
Jan ’24 | CHF 453.70 | CHF 680.88 +50.1% | 19.4% | CHF 965.00 | CHF 315.05 | CHF 353.90 | 16 |
Dec ’23 | CHF 506.20 | CHF 699.00 +38.1% | 17.8% | CHF 965.00 | CHF 315.05 | CHF 335.90 | 16 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 07:26 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lonza Group AG is covered by 50 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Martin Schnee | AlphaValue |
Volker Bosse | Baader Helvea Equity Research |
Charles Pitman-King | Barclays |